Canine Nictitans Gland Prolapse

Canine nictitans gland prolapse, commonly known as cherry eye, is a condition in which the tear-producing gland located within the third eyelid becomes displaced from its normal anatomical position and protrudes visibly at the inner corner of the eye. The condition presents as a smooth, pink to red, round or oval mass arising from behind the third eyelid, and its appearance is the reason for the colloquial name cherry eye. While the condition is not typically painful in its early stages, it can lead to significant ocular complications if left untreated.

The nictitans gland is one of the major tear-producing glands in the dog and is responsible for producing approximately 30 to 50 percent of the aqueous component of the tear film. This contribution makes the gland critically important for maintaining ocular surface health throughout the dog's life. The gland is normally held in position by a connective tissue attachment to the periorbital tissues, but a weakness or absence of this connective tissue attachment allows the gland to prolapse from behind the third eyelid.

Cherry eye is predominantly seen in young dogs, with most cases presenting between the ages of six weeks and two years. The condition has a strong breed predisposition, with brachycephalic breeds and certain other breeds being overrepresented. Cherry eye can affect one or both eyes, and bilateral occurrence is common, with the second eye often becoming affected weeks to months after the first. Some studies report bilateral involvement in approximately 30 to 40 percent of affected dogs.

The condition is not considered a medical emergency, but prompt veterinary evaluation and appropriate treatment are important to preserve the function of the nictitans gland and protect the long-term health of the eye. The primary goal of treatment is to reposition the gland surgically while preserving its tear-producing capacity, as removal of the gland predisposes the dog to keratoconjunctivitis sicca, or dry eye, later in life.

Understanding the anatomy and function of the third eyelid is essential for appreciating the significance of nictitans gland prolapse. The third eyelid, also called the nictitating membrane or membrana nictitans, is a protective structure found in dogs and many other animal species. It is located at the medial canthus, or inner corner, of each eye and consists of a T-shaped cartilage framework covered by conjunctival tissue on both surfaces.

The nictitans gland is a seromucous gland that wraps around the base of the T-shaped cartilage within the third eyelid. This gland contributes a substantial portion of the total tear film production, with estimates ranging from 30 to 50 percent of the aqueous tear output. The remaining tear production comes from the lacrimal gland, which is located in the dorsolateral orbit beneath the orbital rim. Both glands work together to maintain an adequate tear film that protects, lubricates, and nourishes the corneal surface.

The third eyelid itself serves several important protective functions. It acts as a physical shield for the cornea, sweeping across the eye surface to distribute the tear film and remove debris. The third eyelid also contains lymphoid tissue on its bulbar surface, often referred to as conjunctival-associated lymphoid tissue, which plays a role in local immune defense of the ocular surface. This lymphoid tissue can sometimes become hyperplastic, which is a separate condition from gland prolapse but can occur concurrently.

In its normal position, the nictitans gland is held firmly in place by a retinaculum, which is a band of connective tissue that anchors the gland to the periorbital structures. In breeds predisposed to cherry eye, this connective tissue attachment is believed to be congenitally weak, insufficiently developed, or absent, allowing the gland to lose its normal anchorage and prolapse forward past the free edge of the third eyelid. Once prolapsed, the gland is exposed to air and mechanical irritation, which causes it to become inflamed, swollen, and congested, contributing to the characteristic cherry-red appearance.

The accessory lacrimal gland tissue within the third eyelid also plays a role in mucin secretion, which is important for the stability of the tear film. Disruption of normal gland function due to chronic prolapse and inflammation can alter the composition and stability of the tear film, even before any quantitative decrease in tear production is measurable.

The primary cause of nictitans gland prolapse in dogs is a congenital weakness or absence of the connective tissue retinaculum that normally anchors the gland in its anatomical position behind the third eyelid. This structural deficiency is believed to be inherited in predisposed breeds, though the exact mode of inheritance has not been fully characterized. The congenital nature of the defect explains why cherry eye predominantly affects young dogs and why it has such a strong breed predisposition.

The connective tissue attachment between the nictitans gland and the periorbital tissue varies in strength and development among different breeds and individual dogs. In breeds with robust connective tissue attachments, the gland remains securely positioned throughout life. In predisposed breeds, the attachment is insufficient to resist the natural tendency of the gland to prolapse, particularly under conditions that increase gland size or local tissue laxity.

Inflammation of the gland or surrounding tissues can serve as a precipitating factor in a dog that is already predisposed to prolapse. Conjunctivitis, allergic reactions, upper respiratory infections, and other sources of ocular irritation can cause swelling of the nictitans gland, increasing its size and making prolapse more likely. In some cases, the initial prolapse occurs during or immediately after an episode of ocular inflammation, though the underlying structural weakness is the true enabling factor.

The role of lymphoid follicular hyperplasia of the conjunctiva associated with the third eyelid has been discussed as a potential contributing factor. Enlargement of the lymphoid follicles on the bulbar surface of the third eyelid may alter the mechanics of the third eyelid and facilitate gland displacement. However, follicular hyperplasia is common in young dogs and resolves with age, so its role as a direct causative factor is debated.

Mechanical factors may also play a role in some cases. Vigorous rubbing or pawing at the eyes, trauma to the periorbital area, and excessive straining or excitement could theoretically precipitate prolapse in a predisposed dog. However, the overwhelming consensus in veterinary ophthalmology is that the congenital connective tissue deficiency is the fundamental cause, with other factors serving as occasional triggers rather than primary causes.

The hallmark sign of nictitans gland prolapse is the appearance of a smooth, pink to red, rounded mass protruding from behind the third eyelid at the inner corner of the eye. The mass is typically the size of a small pea to a cherry, giving rise to the common name cherry eye. The prolapsed gland may be visible continuously or may intermittently reduce and then re-prolapse, particularly in the early stages of the condition. Over time, the prolapse typically becomes persistent as the gland becomes increasingly inflamed and swollen.

The prolapsed gland often appears congested and edematous due to impaired venous and lymphatic drainage in its displaced position. The exposed surface of the gland is subject to desiccation and mechanical irritation from contact with the eyelids and environmental exposure. This leads to surface inflammation and increased mucoid or mucopurulent discharge from the affected eye. The conjunctiva surrounding the prolapsed gland may appear reddened and irritated.

Secondary signs may develop as a consequence of the gland prolapse. Increased tearing or ocular discharge is common and may be serous, mucoid, or mucopurulent in character. Dogs may paw at or rub the affected eye, which can worsen inflammation and potentially cause corneal abrasions or ulceration. Blepharospasm, which is squinting or involuntary closure of the eyelids, may be present if significant irritation or secondary corneal injury has occurred.

In cases where cherry eye has been present for an extended period without treatment, the chronically exposed and inflamed gland can develop fibrosis and decreased functional capacity. This progressive damage to the gland tissue can impair its ability to produce tears even if it is eventually surgically repositioned. Chronic irritation of the corneal surface may also lead to superficial corneal vascularization, pigmentation, or recurrent corneal ulceration.

Bilateral involvement is common, and owners should be advised that if one eye develops cherry eye, there is a meaningful probability that the opposite eye will be affected as well. The second eye may prolapse within days, weeks, or months of the first. In some dogs, both eyes present simultaneously. Owners should be counseled to monitor the unaffected eye and seek prompt evaluation if signs of gland prolapse appear.

Diagnosis of nictitans gland prolapse is typically straightforward and is based on the characteristic clinical appearance of a smooth, pink to red mass protruding from behind the third eyelid at the medial canthus of the eye. An experienced veterinarian or veterinary ophthalmologist can usually make the diagnosis on visual inspection alone. However, a thorough ophthalmic examination is important to assess for any concurrent ocular conditions and to evaluate the health of the eye prior to surgical intervention.

A complete ophthalmic examination should include evaluation of both eyes, even if only one appears clinically affected, as bilateral disease is common and the contralateral eye may show early signs of gland instability. Schirmer tear testing should be performed to establish a baseline measurement of tear production in both eyes. This baseline is valuable for comparison during post-operative follow-up and for long-term monitoring of tear production throughout the dog's life.

Fluorescein staining of the cornea is performed to check for corneal ulceration or erosion, which can result from mechanical irritation by the prolapsed gland or from self-trauma due to rubbing. Intraocular pressure measurement using tonometry should be performed to rule out concurrent glaucoma, which is rare in this context but is part of a thorough ophthalmic assessment. Examination of the anterior chamber, lens, and fundus helps identify any additional ocular abnormalities.

Differential diagnoses for a mass arising from behind the third eyelid include third eyelid neoplasia, follicular conjunctivitis with third eyelid hyperplasia, third eyelid cartilage eversion, and inflammatory or immune-mediated conditions affecting the third eyelid. Neoplasia of the third eyelid is more common in older dogs and typically presents as an irregular, firm, or ulcerated mass rather than the smooth, rounded appearance of a prolapsed gland. Cartilage eversion of the third eyelid involves a scrolling or bending of the T-shaped cartilage and can sometimes mimic or accompany gland prolapse.

In cases where the diagnosis is uncertain, or when the mass has an atypical appearance, fine needle aspiration cytology or biopsy may be considered to differentiate gland prolapse from neoplastic or other pathologic conditions. However, in the vast majority of cases presenting in young, predisposed breeds, the clinical presentation is sufficiently characteristic to establish the diagnosis without advanced diagnostics.

Surgical repositioning of the prolapsed nictitans gland is the recommended treatment for cherry eye in dogs. The overarching principle of surgical management is to replace the gland to its normal anatomical position and secure it there while preserving the gland's tear-producing function. Removal of the gland, which was commonly performed in the past, is strongly discouraged in modern veterinary ophthalmology because it significantly increases the risk of keratoconjunctivitis sicca later in the dog's life.

The Morgan pocket technique, also known as the mucosal pocket or envelope technique, is one of the most widely performed surgical procedures for cherry eye correction. In this technique, the surgeon creates a pocket in the conjunctiva on the bulbar surface of the third eyelid by making two parallel incisions on either side of the prolapsed gland. The gland is then tucked into this pocket, and the overlying conjunctival edges are sutured closed, burying the gland beneath the conjunctival surface. The pocket technique has reported success rates of approximately 85 to 95 percent for initial resolution.

The orbital rim tacking technique, sometimes called the anchoring or imbrication technique, involves placing sutures that secure the gland or the base of the third eyelid to the periosteum of the orbital rim. This technique aims to recreate the connective tissue attachment that is deficient in affected dogs. Various modifications of the tacking technique have been described, and the procedure can be performed through a conjunctival approach. Success rates for the tacking technique are comparable to the pocket technique, with reported rates of approximately 85 to 95 percent.

Combination techniques that incorporate elements of both the pocket and tacking approaches are also used by some surgeons, particularly in cases where the gland is very large, severely inflamed, or where a previous surgical repair has failed. The choice of technique may be influenced by surgeon preference, experience, the size and degree of inflammation of the prolapsed gland, and whether the case is a primary repair or a revision after previous surgical failure.

Post-surgical recurrence of gland prolapse occurs in a small percentage of cases, estimated at approximately 5 to 15 percent depending on the technique and the breed. Brachycephalic breeds with significant facial conformation differences and very lax connective tissues may have higher recurrence rates. Revision surgery using the same or an alternative technique is typically successful in achieving long-term gland repositioning. Regardless of the technique employed, preservation of the nictitans gland is paramount, and gland excision should be considered only as a last resort when multiple repositioning attempts have failed.

Post-operative care following surgical correction of nictitans gland prolapse is essential for achieving a successful outcome and preventing complications. An Elizabethan collar must be worn continuously for the entire post-operative recovery period, typically two to three weeks, to prevent the dog from rubbing or pawing at the surgical site. Self-trauma to the operated eye is one of the most common causes of surgical failure, as the sutures can be disrupted before adequate healing has occurred.

Topical ophthalmic medications are typically prescribed for the post-operative period and commonly include a topical antibiotic to prevent infection and a topical anti-inflammatory agent to control swelling and discomfort. Antibiotic-steroid combination drops or ointments are frequently used. Oral anti-inflammatory medications or analgesics may also be prescribed to manage post-operative discomfort and reduce swelling. Owners should be instructed on the proper technique for administering eye drops and ointments to ensure medication reaches the eye surface effectively.

Mild to moderate swelling of the third eyelid and surrounding conjunctiva is expected in the immediate post-operative period and typically resolves over one to two weeks. The third eyelid may appear more prominent than normal during the healing phase, which can be concerning to owners but is a normal part of the recovery process. Mild mucoid discharge from the operated eye is common during recovery and should be gently cleaned with a warm, damp cloth.

Exercise restriction is recommended during the recovery period to minimize the risk of trauma to the surgical site and to reduce increases in ocular blood flow and pressure that could compromise the repair. Vigorous play, running, rough housing with other pets, and activities that could result in facial contact should be avoided for at least two to three weeks following surgery. Swimming should be strictly avoided during the recovery period.

Follow-up examinations are typically scheduled at one to two weeks post-operatively to assess healing and again at four to six weeks to confirm successful gland repositioning. Long-term follow-up should include periodic Schirmer tear testing to monitor tear production over the dog's lifetime, as some dogs may develop decreased tear production months to years after surgery, even when the gland has been successfully preserved. Early detection of declining tear production allows timely intervention with artificial tear supplementation to protect the corneal surface.

Nictitans gland prolapse has a pronounced breed predisposition, with certain breeds being affected at a substantially higher rate than the general canine population. Understanding breed-specific risk helps owners and breeders recognize the condition early and seek appropriate veterinary care promptly. The breeds most commonly affected share certain anatomical features, including prominent eyes, shallow orbits, and loose facial skin, though the fundamental defect is the connective tissue weakness anchoring the gland.

English Bulldogs are among the most commonly affected breeds, with cherry eye being a well-recognized condition in this breed. French Bulldogs share this high susceptibility and are frequently presented with cherry eye at a young age. The brachycephalic skull conformation of both breeds, with their shallow orbits and prominent eyes, may contribute to the mechanical factors that facilitate gland prolapse, in addition to the underlying connective tissue weakness.

Beagles represent one of the non-brachycephalic breeds with a documented predisposition to cherry eye. Cocker Spaniels, both American and English varieties, are also commonly affected. Bloodhounds, with their characteristically loose facial skin and prominent haw, are another breed with elevated risk. Lhasa Apsos and Shih Tzus, both brachycephalic toy breeds, are frequently diagnosed with this condition.

Boston Terriers, another brachycephalic breed with prominent eyes, have a well-recognized predisposition to cherry eye. Chinese Shar-Peis, known for their loose, wrinkled skin throughout the body, are also overrepresented. Cavalier King Charles Spaniels, Neapolitan Mastiffs, Cane Corsos, and Great Danes are additional breeds that appear in cherry eye case reports with notable frequency. The Mastiff and giant breed predisposition suggests that overall tissue laxity in large-breed dogs may be a contributing factor.

While breed predisposition is a significant risk factor, cherry eye can occur in any breed, including mixed-breed dogs. Breeders of predisposed breeds should be aware of the condition and its potential hereditary component. Although breeding recommendations specifically targeting cherry eye prevention are difficult due to the incompletely understood inheritance pattern, affected dogs and their close relatives should be carefully considered in breeding decisions. Puppy buyers acquiring breeds at higher risk should be educated about the condition so they can recognize it early and seek appropriate treatment.

While nictitans gland prolapse is a treatable condition with good surgical outcomes in the majority of cases, several potential complications and long-term considerations warrant discussion with dog owners. The most significant long-term concern is the development of keratoconjunctivitis sicca, commonly known as dry eye, which can occur whether the gland has been surgically repositioned or, more commonly, if it has been removed.

Keratoconjunctivitis sicca develops when the tear film is insufficient to maintain corneal health, resulting in chronic ocular surface inflammation, mucoid discharge, corneal vascularization, pigmentation, and potentially corneal ulceration. Because the nictitans gland contributes a substantial portion of total tear production, its loss through surgical excision significantly increases the lifetime risk of dry eye. This is the primary reason that modern veterinary ophthalmology strongly advocates for gland preservation rather than removal. Dogs that have had the gland removed should be monitored with periodic Schirmer tear testing throughout their lives.

Even when the gland has been successfully repositioned, some dogs may experience decreased tear production over time due to gland damage from the prolapse itself, from chronic inflammation prior to surgical correction, or from surgical manipulation. Baseline Schirmer tear testing at the time of diagnosis and at regular intervals after surgery provides a means of tracking tear production and identifying declining values before clinical signs of dry eye develop.

Surgical recurrence is a recognized complication, with reported rates varying from approximately 5 to 15 percent depending on the technique, surgeon experience, and breed. Recurrence may occur within days to weeks of the initial surgery or months to years later. Dogs with recurrent prolapse require revision surgery, and the choice of technique for the revision may differ from the initial procedure. Repeated surgical manipulation of the gland increases the cumulative risk of gland damage and subsequent dry eye.

Cyst formation within the nictitans gland is an uncommon complication that can occur after surgical repositioning. Gland cysts may result from obstruction of gland ductules by scar tissue or suture material and present as a smooth, fluid-filled swelling of the third eyelid. Small cysts may be monitored, while larger or symptomatic cysts may require surgical drainage or marsupialization. Suture-related complications, including suture irritation of the corneal surface, granuloma formation, and premature suture loosening, can also occur but are generally manageable.

The historical approach to treating cherry eye involved surgical excision of the prolapsed nictitans gland, and this practice persisted for many years before the long-term consequences became widely appreciated. As veterinary ophthalmology advanced and long-term follow-up data accumulated, it became clear that gland removal carries a significant risk of inducing keratoconjunctivitis sicca, fundamentally changing the standard of care for this condition. Understanding why gland removal is now strongly discouraged is important for both veterinary professionals and dog owners.

The nictitans gland is not a redundant structure. Its contribution of approximately 30 to 50 percent of total aqueous tear production makes it a critical component of the tear film apparatus. Removal of the gland eliminates this contribution entirely, leaving the lacrimal gland as the sole source of aqueous tear production. While many dogs compensate adequately in the short term, the remaining lacrimal gland may not be able to maintain sufficient tear production indefinitely, particularly as the dog ages or if the lacrimal gland function declines for any reason.

Studies examining the long-term outcomes of nictitans gland excision have reported that a substantial percentage of dogs develop keratoconjunctivitis sicca months to years after gland removal. Reported rates of post-excision dry eye vary across studies but have been documented at levels high enough to constitute a significant clinical concern. The onset may be delayed by years, which historically led to a disconnect between the surgery and its consequences and contributed to the persistence of the excision approach.

Keratoconjunctivitis sicca is a chronic, lifelong condition that requires ongoing management with topical cyclosporine or tacrolimus ointment, artificial tears, and regular veterinary monitoring. The management of dry eye represents a significant financial and time commitment for the dog owner and can be a source of ongoing discomfort for the dog. In severe cases, uncontrolled dry eye can lead to corneal ulceration, secondary infection, corneal scarring, and vision impairment.

Current best practice in veterinary ophthalmology is unequivocal in recommending gland-sparing surgical techniques for cherry eye. The Morgan pocket technique and orbital rim tacking technique both achieve gland repositioning while preserving function. When owners are presented with the option of gland removal, they should be informed of the significant risk of keratoconjunctivitis sicca and encouraged to pursue gland-preserving surgery, even if referral to a veterinary ophthalmologist is necessary to access the appropriate surgical expertise.